When it comes to delivering excellence in targeted drug delivery and infusion care solutions, AIS Healthcare stands at the forefront. With fifteen years of dedicated service since its inception in 2008, this healthcare trailblazer has expanded to encompass eight locations across six states, impacting the lives of over 35,000 patients nationwide. At the core of AIS Healthcare’s success lies its state-of-the-art compounding pharmacies and a cadre of highly skilled pharmacists, who are committed to producing medications of impeccable quality and sterility, resulting in enhanced patient quality of life and superior outcomes.
For over a decade and a half, AIS Healthcare has been unwavering in its commitment to providing patients with exceptional care and support. “We consistently go above and beyond to set higher quality standards for targeted drug delivery and infusion care. Our mission is to improve the quality of life for our patients,” states Simon Castellanos, AIS Healthcare’s Chief Executive Officer. The organization’s future promises to be equally transformative as it continues its journey to uplift the lives of patients and the healthcare professionals it serves.
AIS Healthcare operates advanced 503A specialty pharmacies, where patient-specific prescriptions are compounded for its targeted drug delivery (TDD) division. These pharmacies offer personalized services tailored to meet the unique needs of patients and physicians alike. By utilizing AIS Healthcare’s TDD medication and services, patients can effectively manage chronic pain and spasticity, leading to improved daily functionality.
Furthermore, AIS Healthcare’s Advanced Infusion Care (AIC) division plays a pivotal role in serving patients with complex medical conditions, such as primary immunodeficiency. Supported by a team of highly trained nurses, AIC adopts a team-based approach to intravenous and subcutaneous immunoglobulin therapy patient care. The division boasts locations in Mississippi, Alabama, Georgia, Texas, Florida, and Maryland.
AIS Healthcare’s unwavering commitment to excellence has earned it dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), setting it apart as an industry leader in targeted drug delivery and infusion care. The organization remains dedicated to delivering transformative services across the care continuum, making a significant difference in the lives of its patients.
In conclusion, AIS Healthcare’s fifteen-year journey is a testament to its relentless pursuit of quality and its enduring mission to enhance the lives of patients. With cutting-edge services and unwavering dedication, AIS Healthcare continues to redefine the healthcare landscape, one patient at a time. Healthcare continues to redefine the healthcare landscape, one patient at a time.